Faculty
Thomas M. Wheeler, M.D. Professor and Chair
Education
-
M.D., Baylor College of Medicine, 1977 (High Honors)
Residency
-
Resident, Baylor College of Medicine, Anatomic and Clinical Pathology, 1977-1981
-
Chief Resident, Baylor College of Medicine, 1980-1981
Specialty
-
Anatomic and Clinical Pathology
-
Cytopathology
-
Genitourinary Pathology
-
Pathology of Asbestos Associated Diseases
Board Certification
-
American Board of Pathology, Anatomic and Clinical, 1981, recertified 1999
-
American Board of Pathology, Cytopathology, 1990
Current Position
-
Chairman, Department of Pathology, Baylor College of Medicine, Houston, Texas, 2004-present
Professional Positions Held
-
Harlan J. Spjut, M.D. Professor of Pathology, 2001-present
-
Associate Chairman, Department of Pathology, Baylor College of Medicine, Houston, Texas, 1995-present
-
Professor of Pathology & Urology, Baylor College of Medicine, Houston, Texas, 1995-present
Honors and Awards
-
College:
-
Alpha Chi Honor Society
-
American Institute of Chemists Award (outstanding senior student in Chemistry)
-
Outstanding alumnus, Houston Baptist University, 1997
-
Medical School:
-
Alpha Omega Alpha, 1976--present
-
Stuart A. Wallace Award (outstanding student in Pathology), 1976
-
Award for excellence in Physiology, 1975
-
Faculty:
-
Voted by peers to be included in listing of The Best Doctors in America, 1998-present
-
Herbert Lansky Award, College of American Pathologists, 1999
-
Life Member of the National Registry of Who's Who, 2001
-
Voted by peers to be included in listing of America's Top Doctors, 2001-present
-
George T. Caldwell, MD Distinguished Service Award, Texas Society of Pathologists, 2007
Membership on professional organizations
-
Alpha Omega Alpha
-
American Board of Pathology, Anatomic Pathology Test Committee, 1995-99
-
American Association for Cancer Research
-
American Foundation for Thyroid Patients, Medical Advisory Board, 1998-1999
-
American Medical Association
-
American Society for Clinical Pathology
-
American Society of Cytopathology
-
American Society of Investigative Pathology
-
American Thyroid Association
-
American Urological Association
-
Association of Pathology Chairs
-
College of American Pathologists:
State Advisory Committee, 1994-97
Chairman, 1999-2000
Delegate to House of Delegates, 1993-2003
Government Affairs Committee, 1996-2003
Council on Government and Professional Affairs, 1999-2003
Nominating Committee 2000
Chair, 2001, 2005-2006
Education Committee 2004-present
Council on Scientific Affairs, 2004-present, chair 2005-2009
Board of Governors, 2003-2006
Executive Committee, 2005-present
Chair, Ad Hoc Work Group for Pathology Report Standardization, 2006-2008 -
Harris County Medical Society
-
Houston Society of Clinical Pathologists:
President, 1992
Scientific Seminar Chair 1988, 2001 -
International Society of Urological Pathology
-
Texas Society of Cytology, President, 1988
-
Texas Society of Pathologists:
Alternate Delegate, 1993-1995
Delegate 1995-present
Secretary 1997
President-Elect 1998
President 1999
Chair Nominating Committee 2000 -
The Thyroid Society for Education and Research, Board of Directors, 1993-98
-
U.S. and Canadian Academy of Pathology, Abstract Review Board, 1997-2000, 2006-2009
-
Editorial Board:
-
Human Pathology, 1996-present
-
Prostate, 1999-present
-
Clinical Thyroidology
-
American Journal of Surgical Pathology, 2000-present
-
American Journal of Translational Research, 2008-present
-
Executive Advisory Board:
-
Archives of Pathology & Laboratory Medicine, 2005-present
-
Ad hoc Reviewer:
-
Cancer
-
Journal of Urology
-
Modern Pathology
-
British Journal of Urology
-
Urology
-
Cancer Research
-
Journal of Clinical Oncology
-
Clinical Cancer Research
-
American Journal of Pathology
-
New England Journal of Medicine
Representative Publications
-
Weiss G, Cottrell S, Distler J, Schatz P, Kirstiansen G, Ittmann MI, Haefliger C, Lesche R, Hartmann A, Corman J, Wheeler TM . DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker for biochemical recurrence in prostate cancer patients after radical prostatectomy. J Urol 2008 . In press.
-
Evans AJ, Henry PC, Van der Kwast TH, Tkachuk DC, Watson K, Lockwood GA, Fleshner NE, Cheung C, Belanger EC, Amin MB, Boccon-Gibod L, Bostwick DG, Egevad L, Epstein JI, Grignon DJ, Jones EC, Montironi R, Moussa M, Sweet JM, Trpkov K, Wheeler TM , Srigley JR. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens. Am J Surg Pathol . 2008 Oct; 32 ( 10 ): 1503-12 .
-
Latour M, Amin MB, Billis A, Egevad L, Grignon DJ, Humphrey PA, Reuter VE, Sakr WA, Srigley JR, Wheeler TM , Yang XJ, Epstein JI. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am J Surg Pathol . 2008 Oct; 32 ( 10 ): 1532-9 .
-
Goldsmith JD, Siegal GP, Suster S, Wheeler TM , Brown RW. Reporting guidelines for clinical laboratory reports in surgical pathology. Arch Pathol Lab Med . 2008 Oct; 132 ( 10 ): 1608-16 .
-
Iczkowski KA, Hossain D, Torkko KC, Qian J, Lucia MS, Wheeler TM , Rewcastle JC, Bostwick DG. Preoperative Prediction of Unifocal, Unilateral, Margin-Negative, and Small Volume Prostate Cancer. Urology . 2008 Jun; 71 ( 6 ): 1166-71.
-
Hammerich KH, Hille S, Ayala GE, Wheeler TM , Engers R, Ackermann R, Mueller-Mattheis V. Malignant advanced granulosa cell tumor of the adult testis: case report and review of the literature. Hum Pathol . 2008 May; 39 ( 5 ): 701-9 .
-
Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T , Maru N, Slawin K, Scardino PT. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol . 2008 May; 179 ( 5 Suppl ): S47-51.
-
Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM , Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L; International Task Force on Prostate Cancer and the Focal Lesion Paradigm. Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and Modalities. J Urol . 2007 Dec; 178 ( 6 ): 2260-7
-
Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM , Thompson TC, Old LJ, Wang RF. CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer. Clin Cancer Res . 2007 Dec 1; 13 ( 23 ): 6947-58 .
-
Eastham JA, Kuroiwa K, Ohori M, Serio AM, Gorbonos A, Maru N, Vickers AJ, Slawin KM, Wheeler TM , Reuter VE, Scardino PT. Prognostic significance of location of positive margins in radical prostatectomy specimens. Urology . 2007 Nov; 70 ( 5 ): 965-9 .
-
Yanagisawa N, Li R, Rowley D, Hao L, Kadmon D, Miles BJ, Wheeler TM , Ayala GE. Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol . 2007 Nov;38(11):1611-20.
-
Yang G, Addai J, Wheeler TM , Frolov A, Miles BJ, Kadmon D, Thompson TC. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum Pathol . 2007 Nov;38(11):1688-95.
-
Li R, Erdamar S, Dai H, Wheeler TM , Frolov A, Scardino PT, Thompson TC, Ayala GE. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer. Hum Pathol. 2007 Oct;38(10):1501-7.
-
Ishii J, Ohori M, Scardino P, Tsuboi T, Slawin K, Wheeler T . Significance of the craniocaudal distribution of cancer in radical prostatectomy specimens. Int J Urol . 2007 Sep;14(9):817-21.
-
Cordon-Cardo C, Kotsianti A, Verbel DA, Teverovskiy M, Capodieci P, Hamann S, Jeffers Y, Clayton M, Elkhettabi F, Khan FM, Sapir M, Bayer-Zubek V, Vengrenyuk Y, Fogarsi S, Saidi O, Reuter VE, Scher HI, Kattan MW, Bianco FJ, Wheeler TM , Ayala GE, Scardino PT, Donovan MJ. Improved prediction of prostate cancer recurrence through systems pathology. J Clin Invest . 2007 Jul;117(7):1876-83.